Bryan Garnier

Mickael Chane Du

email

Citi

Andrew Baum

email

Gilbert Dupont

Damien Choplain

email

Goldman Sachs

Tim Woodward

email

Invest Securities

Martial Descoutures

email

Leerink Partners

Michael Schmidt, Ph.D.

email

Oddo Securities

Pierre Corby

email

Portzamparc

Arnaud Guérin

email

The opinions, assessments or forecasts from these analysts on Innate Pharma performance levels and activities are not necessarily representative of Innate Pharma's ownforecasts, nor are they necessarily shared by its management.